Cargando…

Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis

Multiple Sclerosis (MS) is a demyelinating and neurodegenerative disease. Though a specific antigen has not been identified, it is widely accepted that MS is an autoimmune disorder characterized by myelin-directed immune attack. Pharmacological treatments for MS are based on immunomodulatory or immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentile, Antonietta, Musella, Alessandra, De Vito, Francesca, Rizzo, Francesca Romana, Fresegna, Diego, Bullitta, Silvia, Vanni, Valentina, Guadalupi, Livia, Stampanoni Bassi, Mario, Buttari, Fabio, Centonze, Diego, Mandolesi, Georgia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753861/ https://www.ncbi.nlm.nih.gov/pubmed/31572399 http://dx.doi.org/10.3389/fimmu.2019.02197

Ejemplares similares

Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
por: Musella, Alessandra, et al.
Publicado: (2018)

Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation
por: Rizzo, Francesca Romana, et al.
Publicado: (2018)

Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis
por: Dolcetti, Ettore, et al.
Publicado: (2020)

Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2020)

Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2021)

Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis
por: Musella, Alessandra, et al.
Publicado: (2020)

Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2015)

Re-Examining the Role of TNF in MS Pathogenesis and Therapy
por: Fresegna, Diego, et al.
Publicado: (2020)

Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
por: Gentile, Antonietta, et al.
Publicado: (2018)

The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis
por: Mandolesi, Georgia, et al.
Publicado: (2021)

Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2019)

MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis
por: De Vito, Francesca, et al.
Publicado: (2021)

Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity
por: Stampanoni Bassi, Mario, et al.
Publicado: (2019)

Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2016)

A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum
por: Musella, A., et al.
Publicado: (2017)

Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2022)

The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis
por: Dolcetti, Ettore, et al.
Publicado: (2022)

Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis
por: Gentile, Antonietta, et al.
Publicado: (2016)

Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2018)

Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
por: Azzolini, Federica, et al.
Publicado: (2022)

Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity
por: Gilio, Luana, et al.
Publicado: (2022)

Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2021)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

Macrophage Plasticity and Polarization Are Altered in the Experimental Model of Multiple Sclerosis
por: Leuti, Alessandro, et al.
Publicado: (2021)

Synaptic Plasticity Shapes Brain Connectivity: Implications for Network Topology
por: Stampanoni Bassi, Mario, et al.
Publicado: (2019)

Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Inflammation Subverts Hippocampal Synaptic Plasticity in Experimental Multiple Sclerosis
por: Nisticò, Robert, et al.
Publicado: (2013)

Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression
por: Stampanoni Bassi, Mario, et al.
Publicado: (2018)

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
por: Albanese, Maria, et al.
Publicado: (2016)

Case Report: Overlap Between Long COVID and Functional Neurological Disorders
por: Gilio, Luana, et al.
Publicado: (2022)

Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
por: Marfia, Girolama Alessandra, et al.
Publicado: (2022)

A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Cannabinoids in Parkinson's Disease
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
por: Buttari, Fabio, et al.
Publicado: (2021)

Fingolimod Immune Effects Beyond Its Sequestration Ability
por: Sica, Francesco, et al.
Publicado: (2019)

Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint
por: Alborghetti, Marika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vn4pba6ob3i3ecrkj3n3prv7nm